Alopecia in Black Men: The Honest Map
Alopecia in Black men is not one condition but several — and the honest map of hair transplant options, medications and camouflage begins with knowing which one is on the scalp. General information, from named dermatological sources, with no folklore.
Alopecia is simply the clinical word for hair loss, and the first honest thing to say about alopecia in Black men is that it is a map, not a single road.
Dermatology references describe several distinct conditions travelling under the one word — hereditary pattern loss, loss from tension on the hair, patchy autoimmune loss, shedding after illness or stress, and the scarring forms in which follicles themselves are destroyed. Each has a different cause, a different course, and a different answer to the question of what can be done.
This article reports that map as the clinical sources draw it: the types, the treatment landscape as dermatologists describe it, hair transplant options and scalp micropigmentation assessed plainly, and the matter of wearing every outcome with the same standard a man brings to the rest of his presentation.
It is general information only, throughout — not advice for any individual scalp, which is a conversation for a consultation room.
First, the Distinction That Decides Everything: Scarring or Not
The American Society for Dermatologic Surgery's patient reference on hair loss organises the whole field around one divide. Where hair loss is non-scarring, the follicles survive intact and regrowth remains possible; its examples include androgenetic alopecia, alopecia areata, and telogen effluvium — the shedding that can follow significant shifts in physical or emotional health or changes in medication.
In scarring hair loss, inflammation damages the follicle itself and regrowth becomes far harder; the reference names lichen planopilaris, folliculitis decalvans, discoid lupus erythematosus and central centrifugal cicatricial alopecia among its examples.
Nearly every practical question in this territory — whether a treatment can restore hair, whether a transplant is even a candidate procedure, how much urgency an evaluation carries — is downstream of that single distinction, which is why dermatologists establish it first, by examination and, where the picture is uncertain, by scalp biopsy.
Pattern Loss: The Common Road
Androgenetic alopecia — male pattern hair loss — is described across the dermatology literature as the most common form of hair loss in men, hereditary in character.
A dermatologist's guide to male pattern hair loss describes its mechanism in plain terms: follicles genetically sensitive to dihydrotestosterone (DHT), a hormone derived from testosterone, gradually miniaturise — each growth cycle producing a finer hair than the last — in a pattern that typically begins at the hairline and crown.
The same guide describes how dermatologists diagnose it: a history, a physical and microscopic examination of the pattern of thinning, family history, and any signs of scalp inflammation — the examination that separates pattern loss from the other conditions on this map that can imitate it.
Traction: The Loss Written by Tension
Traction alopecia is hair loss from sustained pulling on the hair, and dermatological sources describe it as a matter of tension rather than of fate. A dermatologist's clinical reference on traction alopecia lists the styles carrying the highest risk: tight ponytails and buns, cornrows and braids worn close and heavy, weaves and extensions, locs under constant tension.
For men, the relevant versions are braids, locs and tightly gathered styles worn for long stretches. The same reference describes the condition's fork in the road with unusual clarity: early on, once the tension is removed, follicles that remain viable can recover; where years of traction have scarred the follicle, the loss becomes permanent with medical treatment alone.
Diagnosis, the reference notes, rests on the history of styling practices and clinical examination, supported by dermoscopy and, where uncertain, biopsy. The honest summary the sources support is that traction is the most preventable entry on this map — and the one where timing matters most, because the window in which it is reversible is the early one.
Areata and Effluvium: The Sudden Chapters
Two further non-scarring forms deserve their place on the map because their suddenness alarms. Alopecia areata is described in the clinical literature as an autoimmune condition in which the immune system attacks hair follicles, producing smooth, round patches of loss — on the scalp, and in its beard form, in the beard.
Telogen effluvium is the shedding state: a significant physical or emotional stressor, an illness, or a medication change shifts an unusual share of follicles into the resting phase at once, and the shedding follows some months later.
The ASDS reference groups both among the non-scarring forms, in which follicles are preserved — a categorisation that matters, because it separates these chapters from the scarring forms below and shapes what dermatologists consider possible in each case.
The Scarring Forms, and CCCA in the Family Picture
The scarring alopecias are the serious territory of the map, and the one most associated with Black patients is central centrifugal cicatricial alopecia — CCCA.
Dermatology references describe it consistently: a scarring alopecia that leads to destruction of the hair follicle and permanent hair loss, predominantly affecting middle-aged Black women, beginning at the crown and expanding outward, leaving smooth, shiny skin where follicles once were.
A Black dermatologist's CCCA reference — Dr. Dina Strachan's practice guide — adds that early diagnosis and treatment are crucial to slowing its progression, and that symptoms can include tenderness, itching or burning at the crown — or, in many cases, no symptoms at all. In an article addressed to men, CCCA belongs on the page for two honest reasons.
First, the family reason: a condition that predominantly affects the women of a family — mothers, sisters, partners — is part of the household's health picture, and the family's health record, the subject of our Family Health Summit, is where such diagnoses are kept and known.
Second, the clinical reason: the scarring category is not exclusive to CCCA or to women, and a man whose loss arrives with scalp symptoms — pain, burning, breakage at the crown, patches that shine — is in the territory where dermatologists treat evaluation as time-sensitive, precisely because what scarring takes, it takes permanently.
The Treatment Landscape, as the Sources Describe It
For pattern loss, the dermatology literature names two medications as the established, regulator-approved core. The Boston dermatology guide states it directly: the FDA has approved two medications for male pattern hair loss — minoxidil, a topical treatment applied to the scalp, and finasteride, an oral medication that blocks DHT.
A 2022 evidence review in the Journal of Dermatological Treatment, summarised in a clinical comparison of minoxidil, finasteride and dutasteride, records the honest complications: the medicines differ in mechanism and in side-effect profile — minoxidil's reported effects include unwanted hair growth and, in oral form, cardiovascular symptoms, while finasteride and dutasteride are associated in the literature with sexual and mood-related effects — and dutasteride, though used off-label by some dermatologists, is not FDA-approved for hair loss.
The ASDS reference adds platelet-rich plasma — a patient's own blood, processed and injected into the scalp — among the options dermatologists discuss, alongside transplant surgery.
The pattern across all of these sources is the same, and it is the honest one: these are prescription and procedural territories with real trade-offs, described in the literature as matters for individual clinical judgement — not products with promises attached.
Transplants and SMP, Assessed Plainly
Hair transplantation relocates a patient's own follicles from a donor area to a thinning one; the ASDS reference describes it as a means of restoring hair density in suitable cases.
The candidacy logic the clinical sources describe is unforgiving in a useful way: a transplant redistributes existing hair rather than creating it, so donor supply, the stability of the surrounding loss, and the diagnosis itself govern whether surgery serves a patient at all — in scarring conditions, the traction reference notes, transplantation enters consideration only once the underlying cause has been fully addressed, if at all.
Scalp micropigmentation occupies the other end of the landscape: a non-surgical cosmetic procedure in which tiny deposits of pigment mimic the appearance of follicles, creating the look of density or of a clean buzz cut. Bosley's clinical overview defines SMP and its limits with a candour the field would do well to copy:
“SMP doesn't replace a hair transplant, since it doesn't regrow hair, but it can be an effective alternative for individuals who want the appearance of hair thickness and density without surgery.”— Bosley, via its scalp micropigmentation overview
The same overview prices SMP, as a provider, at commonly $1,500 to $5,000 or more for a complete treatment plan across multiple sessions, with results considered semi-permanent — typically holding their look for about four to eight years before gradually fading.
Those are one provider's published figures, offered here as the landscape's shape rather than a quote for any reader's head.
Between the surgical and cosmetic poles sit the simplest instruments of all: the cut itself, kept short and intentional — the standard our Bald Standard treats as a crown rather than a concession — and the counsel of the chair, in The Chair, where a master barber reads a changing hairline the way a tailor reads a changing shoulder, and adjusts the silhouette accordingly.
What the Evaluation Itself Involves — and the Products Shelf
Because the map's branches diverge so sharply, dermatology sources describe the diagnostic visit as the load-bearing appointment of the whole subject.
The Boston guide's account of how dermatologists diagnose pattern loss — a history, a physical and microscopic examination of the pattern of thinning, family history, and a check for signs of scalp inflammation — generalises across the map: the traction reference describes diagnosis resting on styling history and clinical examination, supported by dermoscopy to assess follicular density and signs of scarring, with a scalp biopsy where the picture remains uncertain.
The sequence matters more than any single test. A scalp that is losing hair for two different reasons at once — pattern loss at the crown, traction at the edges — is a common picture in the clinical descriptions, and it is precisely the picture that a shelf of products, bought on hope, cannot sort out.
That shelf deserves its own honest paragraph. The ASDS patient reference closes its guidance with a list of cautions, and one of them is carried here in the society's own interest: among its don'ts is purchasing unproven products.
The marketplace addressed to thinning hair is wide, confident and largely unexamined by regulators; the clinical sources, by contrast, are narrow — a short list of approved medications, a set of procedural options, and camouflage of genuine craft.
A reader measuring any product claim against that short list has the shape of the evidence right: if a preparation is not on it, the sources describe it, at best, as unproven.
Wearing Every Outcome Well
The map, honestly drawn, ends in several different countries: hair kept, hair restored in part, hair camouflaged with skill, hair released entirely. The well-kept standard does not rank them.
What it asks is that the outcome be chosen with full information and worn without apology — a decision made in a consultation room, executed by masters, and carried into every room afterward at the same altitude as everything else in a man's presentation.
The wider file on keeping skin and hair at this level lives in The Skin We're In. And the standing close of every health page in this magazine applies here in its exact form: this has been general information, drawn from named clinical and dermatological sources — the individual word belongs to a dermatologist who knows Black skin.
The Skin We're In: Hyperpigmentation, Melanin Experts, and the Dermatologist Who Gets It
The Bald Standard: Why the Clean Head Is a Crown
The Chair: Barbers, Salons, and the Appointments That Run Black Life
The Family Health Summit: One Weekend, Every Number Known
Black Excellence: The Black Men Collection
American Society for Dermatologic Surgery — “Hair Loss”
Boston Derm Advocate — “Dermatologist Guide on Treating Male Pattern Hair Loss”
Dr. Ophelia Dermatology — “Traction Alopecia”
Commonwealth Dermatology — “Central Centrifugal Cicatricial Alopecia”
Aglow Dermatology (Dr. Dina Strachan) — “Central Centrifugal Cicatricial Alopecia (CCCA)”
Dr. Kumar Discovery — “Minoxidil vs Finasteride vs Dutasteride for Hair Loss” (review of Journal of Dermatological Treatment evidence)
Bosley — “Scalp Micropigmentation (SMP): What It Is & Why It's a Great Option”
Questions & Answers
Who will you meet on this page?
Alopecia in Black men is not one condition but several — and the honest map of hair transplant options, medications and camouflage begins with knowing which one is on the scalp. General information, from named dermatological sources, with no folklore. It links to 5 stories and articles — open any card to read the full piece.
What makes these stories worth reading?
Alopecia in Black men is not one condition but several — and the honest map of hair transplant options, medications and camouflage begins with knowing which one is on the scalp. General information, from named dermatological sources, with no folklore.
How do I read the full stories on Alopecia in Black Men: The Honest Map?
Choose any card on this page. Each one opens a full page of its own — the complete story or article, with its sources linked.